论文部分内容阅读
目的探讨氨溴特罗口服液联合阿奇霉素治疗小儿支原体肺炎的临床疗效。方法将83例支原体肺炎患儿随机分成两组,治疗组42例口服氨溴特罗口服液联合阿奇霉素10mg/(kg.d)静脉滴注,对照组41例仅静脉滴注阿奇霉素10mg/(kg.d),疗程5d。结果治疗组总有效率治疗组为92.8%,对照组为82.9%,两组间有有显著差异(P<0.05);治疗组发热、咳嗽、肺部啰音消失和胸部X线恢复正常时间明显少于对照组(P<0.05)。结论氨溴特罗口服液联合阿奇霉素治疗小儿支原体肺炎可缩短疗程,减轻临床症状。
Objective To investigate the clinical efficacy of ambroxol oral azithromycin in the treatment of children with mycoplasma pneumonia. Methods Eighty-three children with mycoplasmal pneumonia were randomly divided into two groups. 42 cases in the treatment group were treated with oral administration of ambroxol 10 mg / (kg.d) intravenously and 41 cases in the control group were given intravenous azithromycin only 10 mg / kg .d), course of treatment 5d. Results The total effective rate of the treatment group was 92.8% in the treatment group and 82.9% in the control group, with significant difference between the two groups (P <0.05). The fever, cough, disappearance of the pulmonary rales and chest X-ray recovery time in the treatment group were normal Less than the control group (P <0.05). Conclusion Ambroxol oral azithromycin in children with mycoplasma pneumonia can shorten the course of treatment, reduce clinical symptoms.